We exist to ensure that each patient gets the right drug, at the right time, to beat their cancer. To do this, we apply advances in machine learning and artificial intelligence to some of the world’s largest cancer datasets. Our technology can detect relapse earlier, predict response to therapy more accurately & reduce ineffective treatment regimens.
Our operating system, OncOS, makes these data accessible to oncologists and helps power adoption of precision oncology. Our biomarker discovery engine, OncAI, helps pharmaceutical companies with complex biomarker discovery for clinical trial stratification and patient selection.
Powering access to precision oncology for all patients, enabling
every oncologist to become a molecular oncologist, and maximizing treatment effectiveness in clinical trials & routine practice.
At CCG, we believe that increasing amounts of clinical and genomic data have the potential to enable oncologists to make smarter decisions about which drug to use in which circumstance. To power our analytics, we carry out research at the cutting edge of machine learning and cancer genomics. Find out about our latest projects, how to collaborate with us, or request access to some of our open-source tools here.